Insulin glargine and lixisenatide and Taclonex Topical Suspension
Determining the interaction of Insulin glargine and lixisenatide and Taclonex Topical Suspension and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: betamethasone / calcipotriene topical
Brand name: Enstilar, Taclonex, Taclonex Scalp, Dovobet
Synonyms: Betamethasone and calcipotriene (topical), Calcipotriene and Betamethasone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Tacrine
- Insulin glargine and lixisenatide-Tacrolimus
- Insulin glargine and lixisenatide-Tacrolimus (Systemic)
- Insulin glargine and lixisenatide-Tacrolimus Capsules
- Insulin glargine and lixisenatide-Tacrolimus Extended-Release Capsules
- Insulin glargine and lixisenatide-Tacrolimus Extended-Release Tablets
- Taclonex Topical Suspension-Insulin glargine and lixisenatide Subcutaneous
- Taclonex Topical Suspension-Insulin glargine, recombinant Subcutaneous
- Taclonex Topical Suspension-Insulin glulisine
- Taclonex Topical Suspension-Insulin Glulisine (Cartridges and Pens)
- Taclonex Topical Suspension-Insulin Glulisine (Vials)
- Taclonex Topical Suspension-Insulin glulisine Subcutaneous